Abiopharma

🔍 Goodburn Mark A. (Director)

Company: C. H. ROBINSON WORLDWIDE, INC. (CHRW)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | shares_owned_after: 2,280.00
• Acquired 219 shares of Phantom Stock (Restricted Stock Units) (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 12,759.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Each phantom/restricted stock unit will be paid in one share of common stock.
• F2: Reflects restricted stock units granted in connection with the reporting person's election to defer receipt of his most recent quarterly cash retainer payment.
• F3: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.